Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
Revenues | 14,925.0 | 15,878.0 | 16,659.0 | 16,887.0 | 18,271.0 | 21,853.0 | 21,903.0 | 19,652.0 |
Revenue growth | -6.0% | -4.7% | -1.4% | -7.6% | -16.4% | -0.2% | 11.5% | -3.1% |
Cost of goods sold | 7,952.0 | 8,284.0 | 8,933.0 | 9,351.0 | 9,975.0 | 11,237.0 | 10,250.0 | 8,296.0 |
Gross profit | 6,973.0 | 7,594.0 | 7,726.0 | 7,536.0 | 8,296.0 | 10,616.0 | 11,653.0 | 11,356.0 |
Gross margin | 46.7% | 47.8% | 46.4% | 44.6% | 45.4% | 48.6% | 53.2% | 57.8% |
Sales and marketing | 2,265.0 | 2,429.0 | 2,498.0 | 2,614.0 | 2,916.0 | 3,395.0 | 3,583.0 | 3,478.0 |
Research and development | 838.0 | 967.0 | 997.0 | 1,010.0 | 1,213.0 | 1,778.0 | 2,077.0 | 1,525.0 |
General and administrative | 1,180.0 | 1,099.0 | 1,173.0 | 1,192.0 | 1,298.0 | 1,451.0 | 1,390.0 | 1,360.0 |
EBITA | -54.0 | 2,933.0 | 3,440.0 | 2,322.0 | 4,618.0 | 3,905.0 | 4,488.0 | 3,575.0 |
EBITA margin | -0.4% | 18.5% | 20.6% | 13.8% | 25.3% | 17.9% | 20.5% | 18.2% |
Amortization of intangibles | | 802.0 | 1,020.0 | 1,113.0 | 1,166.0 | 1,444.0 | 993.0 | 838.0 |
EBIT | -54.0 | 2,131.0 | 2,420.0 | 1,209.0 | 3,452.0 | 2,461.0 | 3,495.0 | 2,737.0 |
EBIT margin | -0.4% | 13.4% | 14.5% | 7.2% | 18.9% | 11.3% | 16.0% | 13.9% |
Pre-tax income | -3,065.0 | 658.0 | -4,406.0 | -1,265.0 | -2,596.0 | -18,379.0 | 824.0 | 2,352.0 |
Income taxes | -638.0 | 211.0 | -168.0 | -278.0 | -195.0 | -1,933.0 | 521.0 | 634.0 |
Tax rate | 20.8% | 32.1% | 3.8% | 22.0% | 7.5% | 10.5% | 63.2% | 27.0% |
Net income | -2,406.0 | 417.0 | -3,990.0 | -998.0 | -2,399.0 | -16,525.0 | 68.0 | 1,573.0 |
Net margin | -16.1% | 2.6% | -24.0% | -5.9% | -13.1% | -75.6% | 0.3% | 8.0% |
|
Diluted EPS | ($2.17) | $0.38 | ($3.64) | ($0.91) | ($2.35) | ($16.26) | $0.07 | $1.82 |
Shares outstanding (diluted) | 1,110.0 | 1,107.0 | 1,095.0 | 1,091.0 | 1,021.0 | 1,016.0 | 961.0 | 864.0 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|